Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials.
Papp
Kim A
KA
Probity Medical Research, Waterloo, Ontario, Canada. kapapp@probitymedical.com
Signorovitch
James
J
Ramakrishnan
Karthik
K
Yu
Andrew P
AP
Gupta
Shiraz R
SR
Bao
Yanjun
Y
Mulani
Parvez M
PM